Online inquiry

IVTScrip™ mRNA-Human ALDH1A2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK17795MR)

This product GTTS-WK17795MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ALDH1A2 protein. This product can be used in Cancer stem cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001206897.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 8854
UniProt ID O94788
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ALDH1A2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK17795MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK22330MR IVTScrip™ mRNA-Human ARIH2, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARIH2
GTTS-WK23677MR IVTScrip™ mRNA-Human ATP11B, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ATP11B
GTTS-WK17192MR IVTScrip™ mRNA-Human Aldehyde Dehydrogenase 1-A1, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA Aldehyde Dehydrogenase 1-A1
GTTS-WK23336MR IVTScrip™ mRNA-Human ATAD2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ATAD2
GTTS-WK18461MR IVTScrip™ mRNA-Human AMT, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AMT
GTTS-WK28764MR IVTScrip™ mRNA-Human ATHL1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ATHL1
GTTS-WK15617MR IVTScrip™ mRNA-Human AGTPBP1, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AGTPBP1
GTTS-WK20200MR IVTScrip™ mRNA-Human ALDH3A2, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ALDH3A2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW